Hospital News and Research

RSS

Exelixis reports interim data from phase 2 RDT trial for epithelial ovarian cancer

Exelixis, Inc. today reported interim data from the cohort of patients with advanced epithelial ovarian cancer, primary peritoneal, or fallopian tube carcinoma treated with XL184 in an ongoing phase 2 adaptive randomized discontinuation trial (RDT).

18 Nov 2010

Center for Medicare and Medicaid Innovation launches projects to improve care, reduce cost

Kaiser Health News: "Promising fast action, the new Center for Medicare and Medicaid Innovation is launching a series of initiatives aimed at improving medical care while reducing its cost, officials said Tuesday. ... In one initiative, eight states will participate in a Medicare demonstration project to evaluate the effectiveness of doctors and other health professionals working 'in a more integrated fashion and receiving more coordinated payment,' according to CMS, the parent agency of the center and a part of the Department of Health and Human Services.

18 Nov 2010

Study shows end-of-life care varies widely

A new study released by the Dartmouth Atlas of Health Care finds that "America's hospitals treat patients with life-ending cancers very differently in their final months, with some deploying chemotherapy and other life-prolonging efforts until the end and others directing most of their patients into hospice," reports Kaiser Health News. The aggressive care may not be best for patients, and hospice may be a "more humane way to die," the report argues. A point the report doesn't address: that aggressive treatment "also adds to the drain on Medicare's pocketbook."

18 Nov 2010

Researchers are revolutionizing treatment of cardiovascular disease through regenerative stem cell therapy

Northwestern Medicine physician researchers are revolutionizing treatment of cardiovascular disease by utilizing patients' own stem cells to regenerate heart and vascular tissue.

18 Nov 2010

VX-770 drug candidate improves lung function in people with cystic fibrosis

In a study published in this week's New England Journal of Medicine, treatment with a new drug candidate known as VX-770 resulted in improvements in lung function and markers of disease in a Phase 2 clinical trial of 39 people with cystic fibrosis (CF). There were no discontinuations due to adverse events in the study, and the frequency of adverse events was similar across the study groups.

18 Nov 2010

Hospice or hospital? Where you die depends on where you live

America's hospitals treat patients with life-ending cancers very differently in their final months, with some deploying chemotherapy and other life-prolonging efforts until the end and others directing most of their patients into hospice, a new study finds.

18 Nov 2010

Krieger Eye Institute at Sinai Hospital opens new center for treatment of retinal diseases

The Krieger Eye Institute at Sinai Hospital opened a new center for the treatment of retinal diseases in November. The retina is the layer of tissue at the back of the eye that converts images to electrical impulses. These electrical signals are then perceived by the brain as sight.

18 Nov 2010

U-Systems initiates EASY study for screening breast cancer

U-Systems, the leader in Automated Breast Ultrasound technology announced participant enrollment has begun in the European Asymptomatic Screening Study (EASY) at Capio Saint Göran Hospital, in Stockholm, Sweden.

18 Nov 2010

Nanotrope assay receives U.S. patent for diagnosing influenza and viral infections

Nanotrope, Inc. announced today that it has been issued United States patent #7,829,272 covering its ground-breaking diagnostic test for influenza and other viral infections.

17 Nov 2010

New pharmacogenetic test enables a personalized medicine approach

Luminex Corporation, today announced that it has commercially launched its first pharmacogenetic test, the xTAG CYP2D6 Kit, which recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

From Luminex 17 Nov 2010

New investigational drug improves lung function in CF patients

An investigational drug targeting a defective protein that causes cystic fibrosis has been shown to improve lung function in a small study of CF patients, according to findings published Nov. 18, 2010, in the New England Journal of Medicine.

17 Nov 2010

Prime Healthcare announces acquisition of Alvarado Hospital

Prime Healthcare Services, Inc., which owns and/or operates 13 acute care hospitals in California, announced the acquisition of Alvarado Hospital in San Diego, CA, from Plymouth Health, a privately-held, Los Angeles-based company that has owned and operated the hospital since January 2007.

17 Nov 2010

GST debates continue & heath reforms come under threat

The federal opposition demands more transparency from the Australian government on how much GST the states will have to hand over under a new health plan. Early this year all states apart from WA, agreed to hand over a third of their GST payments for the federal government to take responsibility for 60 per cent of the cost of running, staffing and building public hospitals. This is estimated to deliver $7.4 billion in funding for extra hospital beds, support for GPs, boosted aged care services and training for more doctors and nurses.

17 Nov 2010

13-hour lifesaving heart/liver transplant performed on pulmonary atresia patient

A 28-year old man from Georgia, David Krech, is recovering from a rare, lifesaving heart/liver transplant on October 15 at the University of Maryland Medical Center. The 13-hour operation followed a five-month journey as he awaited a suitable heart and liver donor.

17 Nov 2010

Study reveals very high cumulative estimated effective doses to patients undergoing MPI

Multiple testing with the cardiac diagnostic imaging technique of myocardial perfusion imaging is common, and in many patients is associated with a high cumulative estimated radiation dose, according to a study in the November 17 issue of JAMA.

17 Nov 2010

St. Jude organizes tobacco cessation program for cancer survivors who smoke

Cancer survivors who smoke and need help quitting can receive help through a tobacco cessation program organized by St. Jude Children's Research Hospital.

17 Nov 2010

Cholesterol-lowering statin therapy benefits patients with calcium buildup in arteries

Rolling back suggestions from previous studies, a Johns Hopkins study of 950 healthy men and women has shown that taking daily doses of a cholesterol-lowering statin medication to protect coronary arteries and ward off heart attack or stroke may not be needed for everyone.

17 Nov 2010

Mayo Clinic to establish pencil beam proton scanning facilities in Minnesota, Arizona and Florida

Mayo Clinic today announced plans to establish the Mayo Clinic Proton Beam Therapy Program as part of Mayo's national three-site cancer center in Minnesota, Arizona and Florida. The new program will employ intensity modulated proton therapy — based on pencil beam scanning — which is a more precise form of proton therapy treatment that allows greater control over radiation doses, shorter treatment times and fewer side effects. It is also believed to be more cost effective in selected patients.

17 Nov 2010

Combination of two devices increases long-term survival in cardiac arrest patients

A combination of two devices could save the lives of several thousand cardiac arrest patients each year if implemented nationwide, suggests results of a clinical trial presented at today's American Heart Association Resuscitation Science Symposium.

17 Nov 2010

Cardiac surgery leads to stroke, seizure and neurological complications: Report

Strokes, seizures and other neurological complications related to heart surgery account for "considerable morbidity and mortality," Loyola University Health System neurologists report in the November issue of the journal Hospital Practice.

17 Nov 2010

Hospital News and Research

Exelixis reports interim data from phase 2 RDT trial for epithelial ovarian cancer

Center for Medicare and Medicaid Innovation launches projects to improve care, reduce cost

Study shows end-of-life care varies widely

Researchers are revolutionizing treatment of cardiovascular disease through regenerative stem cell therapy

VX-770 drug candidate improves lung function in people with cystic fibrosis

Hospice or hospital? Where you die depends on where you live

Krieger Eye Institute at Sinai Hospital opens new center for treatment of retinal diseases

U-Systems initiates EASY study for screening breast cancer

Nanotrope assay receives U.S. patent for diagnosing influenza and viral infections

New pharmacogenetic test enables a personalized medicine approach

New investigational drug improves lung function in CF patients

Prime Healthcare announces acquisition of Alvarado Hospital

GST debates continue & heath reforms come under threat

13-hour lifesaving heart/liver transplant performed on pulmonary atresia patient

Study reveals very high cumulative estimated effective doses to patients undergoing MPI

St. Jude organizes tobacco cessation program for cancer survivors who smoke

Cholesterol-lowering statin therapy benefits patients with calcium buildup in arteries

Mayo Clinic to establish pencil beam proton scanning facilities in Minnesota, Arizona and Florida

Combination of two devices increases long-term survival in cardiac arrest patients

Cardiac surgery leads to stroke, seizure and neurological complications: Report

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News